Literature DB >> 17443456

[Screening of cognitive functions and the prediction of incident dementia by means of the SIDAM].

Horst Bickel1, Edelgard Mösch, Hans Förstl.   

Abstract

OBJECTIVE: The suitability of the SIDAM (Structured Interview for the Diagnosis of Dementia) for the detection of pre-clinical stages of dementia.
METHODS: Prospective study of a sample of 794 non-demented elderly persons in the age bracket from 65 to 85 who were initially being treated in general hospitals. A cognitive screening with the SIDAM was performed during their stay in the hospital. After discharge the occurrence of dementia was determined in four follow-up studies at one-year intervals.
RESULTS: During the follow-up, 100 newly developed cases of dementia were diagnosed. A lower performance in the SIDAM was associated with a significantly higher risk of the development of dementia. In comparison with the upper quartile in total SIDAM score the relative risk of a dementia amounted to 2.6 (1.0-6.8) for the second quartile, 4.5 (1.9-11.0) for the third quartile and 13.3 (5.7-31.1) for the fourth quartile. The highest predictive validity was found for memory performance, in particular for free delayed recall.
CONCLUSIONS: Risk groups for dementia can be identified by the use of a brief cognitive screening procedure.

Entities:  

Mesh:

Year:  2007        PMID: 17443456     DOI: 10.1055/s-2006-951973

Source DB:  PubMed          Journal:  Psychiatr Prax        ISSN: 0303-4259


  3 in total

1.  [Antidementia drugs--response or non-response?].

Authors:  H Förstl
Journal:  Internist (Berl)       Date:  2008-03       Impact factor: 0.743

2.  [Advances in the diagnostics of Alzheimer's disease].

Authors:  U Fiedler; J Wiltfang; N Peters; J Benninghoff
Journal:  Nervenarzt       Date:  2012-05       Impact factor: 1.214

3.  Childhood trauma and PTSD symptoms increase the risk of cognitive impairment in a sample of former indentured child laborers in old age.

Authors:  Andrea Burri; Andreas Maercker; Sandy Krammer; Keti Simmen-Janevska
Journal:  PLoS One       Date:  2013-02-26       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.